FBInvestor
Stocks / Apimeds Pharmaceuticals Us I
Institutional Ownership

Apimeds Pharmaceuticals Us I

CUSIP 03771D102COM SHSAPUSQ1 2026

Institutional Holders
4
13F filers
Shares Held
328.8K
Aggregate institutional
Institutional Value
$588.3K
Q1 2026
Net New Holders
-2
1 new · 3 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions1
Increased2
Decreased0
Sold out3

Institutional Holders

4 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Hemenway Trust Co LLC274.0K$490.3K0Held
2Geode Capital Management, LLC40.1K$71.7K+5.2KAdded
3Two Sigma Securities, LLC10.6K$18.9K+10.6KNew
4Ubs Group AG4.2K$7.5K+3.6KAdded